Original Research
Accepted on 30 Jan 2026
CRIP1 promotes docetaxel resistance and immune-associated cell death modulation in prostate cancer
in Experimental Pharmacology and Drug Discovery
- 123 views
Original Research
Accepted on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 30 Jan 2026
in Pharmacology of Infectious Diseases
Case Report
Published on 30 Jan 2026
in Pharmacogenetics and Pharmacogenomics
Data Report
Published on 30 Jan 2026
in Pharmacoepidemiology
Original Research
Published on 30 Jan 2026
in Drug Metabolism and Transport
Original Research
Published on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 30 Jan 2026
in Respiratory Pharmacology
Original Research
Published on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery
Review
Published on 30 Jan 2026
in Ethnopharmacology
Original Research
Published on 30 Jan 2026
in Renal Pharmacology
Original Research
Published on 30 Jan 2026
in Ethnopharmacology
Original Research
Published on 30 Jan 2026
in Renal Pharmacology
Original Research
Published on 30 Jan 2026
in Inflammation Pharmacology
Systematic Review
Published on 30 Jan 2026
in Gastrointestinal and Hepatic Pharmacology
Correction
Published on 30 Jan 2026
in Ethnopharmacology
Original Research
Published on 30 Jan 2026
in Experimental Pharmacology and Drug Discovery
Review
Published on 30 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Mini Review
Accepted on 29 Jan 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 29 Jan 2026
in Drugs Outcomes Research and Policies
Original Research
Accepted on 29 Jan 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 29 Jan 2026
in Ethnopharmacology
Perspective
Accepted on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Perspective
Accepted on 29 Jan 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs